Health Insurance Innovations, Inc. (NASDAQ:HIIQ) – Investment analysts at First Analysis raised their Q3 2017 earnings per share (EPS) estimates for shares of Health Insurance Innovations in a report issued on Sunday. First Analysis analyst now expects that the financial services provider will post earnings of $0.41 per share for the quarter, up from their prior forecast of $0.38. First Analysis also issued estimates for Health Insurance Innovations’ Q4 2017 earnings at $0.43 EPS.

Health Insurance Innovations (NASDAQ:HIIQ) last issued its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $0.46 earnings per share for the quarter, topping analysts’ consensus estimates of $0.33 by $0.13. The business had revenue of $61.80 million for the quarter, compared to analyst estimates of $53.69 million. Health Insurance Innovations had a return on equity of 23.92% and a net margin of 5.56%. The business’s quarterly revenue was up 38.9% compared to the same quarter last year.

ILLEGAL ACTIVITY NOTICE: This article was published by Daily Political and is the property of of Daily Political. If you are reading this article on another website, it was illegally stolen and republished in violation of international copyright and trademark laws. The legal version of this article can be read at https://www.dailypolitical.com/2017/08/09/brokers-set-expectations-for-health-insurance-innovations-inc-s-q3-2017-earnings-hiiq.html.

HIIQ has been the subject of several other research reports. Zacks Investment Research lowered Health Insurance Innovations from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 3rd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $35.00 target price (up previously from $30.00) on shares of Health Insurance Innovations in a research note on Monday, July 17th. Canaccord Genuity reaffirmed a “buy” rating and issued a $39.00 target price (up previously from $30.00) on shares of Health Insurance Innovations in a research note on Friday, August 4th. Raymond James Financial, Inc. reaffirmed a “market perform” rating on shares of Health Insurance Innovations in a research note on Monday, June 26th. Finally, Craig Hallum initiated coverage on Health Insurance Innovations in a research note on Monday, June 12th. They issued a “buy” rating and a $28.00 target price for the company. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $30.83.

Shares of Health Insurance Innovations (NASDAQ HIIQ) opened at 31.40 on Wednesday. Health Insurance Innovations has a 52-week low of $3.92 and a 52-week high of $32.95. The firm has a 50 day moving average price of $25.90 and a 200-day moving average price of $20.28. The company has a market cap of $362.67 million, a price-to-earnings ratio of 25.40 and a beta of 0.68.

In other Health Insurance Innovations news, CEO Bruce Telkamp sold 18,745 shares of the business’s stock in a transaction that occurred on Friday, May 12th. The stock was sold at an average price of $21.94, for a total value of $411,265.30. Following the completion of the sale, the chief executive officer now owns 107,211 shares in the company, valued at $2,352,209.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sheldon Wang sold 12,417 shares of the business’s stock in a transaction that occurred on Friday, May 12th. The shares were sold at an average price of $21.18, for a total value of $262,992.06. Following the completion of the sale, the insider now owns 226,251 shares of the company’s stock, valued at approximately $4,791,996.18. The disclosure for this sale can be found here. In the last ninety days, insiders sold 217,804 shares of company stock valued at $5,488,721. 30.00% of the stock is owned by insiders.

Hedge funds have recently made changes to their positions in the stock. Tudor Investment Corp ET AL bought a new stake in shares of Health Insurance Innovations during the first quarter valued at $648,000. Dialectic Capital Management LP increased its stake in shares of Health Insurance Innovations by 39.7% in the first quarter. Dialectic Capital Management LP now owns 496,300 shares of the financial services provider’s stock valued at $7,941,000 after buying an additional 141,083 shares during the last quarter. Menta Capital LLC bought a new stake in shares of Health Insurance Innovations during the first quarter valued at $909,000. Emerald Mutual Fund Advisers Trust bought a new stake in shares of Health Insurance Innovations during the first quarter valued at $6,383,000. Finally, Millrace Asset Group Inc. bought a new stake in shares of Health Insurance Innovations during the first quarter valued at $1,840,000. Hedge funds and other institutional investors own 72.13% of the company’s stock.

About Health Insurance Innovations

Health Insurance Innovations, Inc is a developer, distributor and cloud-based administrator of individual and family health insurance plans (IFPs) and supplemental products, which include short-term medical (STM) insurance plans, and guaranteed-issue and underwritten hospital indemnity plans. The Company also develops, distributes and administers supplemental products, which include a range of additional insurance and non-insurance products, such as pharmacy benefit cards, dental plans, vision plans, cancer/critical illness plans, deductible and gap protection plans, and life insurance policies that are purchased as supplements to IFP.

Earnings History and Estimates for Health Insurance Innovations (NASDAQ:HIIQ)

Receive News & Ratings for Health Insurance Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Health Insurance Innovations Inc. and related companies with MarketBeat.com's FREE daily email newsletter.